Literature DB >> 9809956

Differentiating thrombus from pannus formation in obstructed mechanical prosthetic valves: an evaluation of clinical, transthoracic and transesophageal echocardiographic parameters.

J Barbetseas1, S F Nagueh, C Pitsavos, P K Toutouzas, M A Quiñones, W A Zoghbi.   

Abstract

OBJECTIVES: We sought to determine the clinical and echocardiographic parameters that differentiate thrombus from pannus formation as the etiology of obstructed mechanical prosthetic valves.
BACKGROUND: Distinction of thrombus from pannus on obstructed prosthetic valves is essential because thrombolytic therapy has emerged as an alternative to reoperation.
METHODS: We analyzed clinical, transthoracic and transesophageal echocardiography (TEE) data in 23 patients presenting with 24 obstructed prosthetic valves and compared the findings to pathology at surgery.
RESULTS: Fourteen valves had thrombus and 10 had pannus formation. Patients with thrombus had a shorter duration from time of valve insertion to malfunction, shorter duration of symptoms, but similar New York Heart Association functional class at the time of operation. Patients with thrombus had a lower rate of adequate anticoagulation (21% vs. 89%; p=0.0028). Pannus formation was more common in the aortic position (70% vs. 21%; p=0.035). Abnormal prosthetic valve motion was detected by TEE in all cases with thrombus formation but in 60% with pannus (p=0.0198). Thrombi were larger than pannuses (total length 2.8+/-2.47 cm vs. 1.17+/-0.43 cm; p=0.038). This was mostly due to extension of thrombi into the left atrium in prosthetic mitral valves. Thrombi appeared as a soft mass on the valve in 92% of cases, whereas 29% of pannuses had a soft echo density (p= 0.007). Ultrasound video intensity ratio, derived as the videointensity of the mass to that of the prosthetic valve, was lower in the thrombus group (0.46+/-0.14 vs. 0.71+/-0.17, p=0.006). A videointensity ratio of <0.70 had a positive predictive value of 87% and a negative predictive value of 89% for thrombus. Duration from onset of symptoms to reoperation of <1 month separated thrombus from pannus formation. The best objective clinical parameter for prediction of thrombus was inadequate anticoagulation, whereas the best TEE parameters were qualitative and quantitative ultrasound intensity of the mass. The presence of either inadequate anticoagulation or a soft mass by TEE improved the predictive power of either parameter alone and was similar to that of ultrasound videointensity ratio.
CONCLUSIONS: Duration of symptoms, anticoagulation status and qualitative and quantitative ultrasound intensity of the mass obstructing a mechanical prosthetic valve can help differentiate pannus formation from thrombus and may therefore be of value in refining the selection of patients for thrombolytic therapy of prosthetic valve obstruction.

Entities:  

Mesh:

Year:  1998        PMID: 9809956     DOI: 10.1016/s0735-1097(98)00385-4

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  49 in total

1.  Intracardiac echocardiography to diagnose pannus formation after aortic valve replacement.

Authors:  Yoshiya Yamamoto; Takahiro Ohara; Akira Funada; Hiroyuki Takahama; Makoto Amaki; Takuya Hasegawa; Yasuo Sugano; Hideaki Kanzaki; Toshihisa Anzai
Journal:  J Echocardiogr       Date:  2016-01-05

2.  Dysfunction of mechanical heart valve prosthesis: experience with surgical management in 48 patients.

Authors:  Wei-Guo Ma; Bin Hou; Adiljan Abdurusul; Ding-Xu Gong; Yue Tang; Qian Chang; Jian-Ping Xu; Han-Song Sun
Journal:  J Thorac Dis       Date:  2015-12       Impact factor: 2.895

Review 3.  Case study and review: treatment of tricuspid prosthetic valve thrombosis.

Authors:  David Yi Zhang; Jay Lozier; Richard Chang; Vandana Sachdev; Marcus Y Chen; Jennifer L Audibert; Keith A Horvath; Douglas R Rosing
Journal:  Int J Cardiol       Date:  2011-10-14       Impact factor: 4.164

4.  Fibrinolytic treatment for recurrent left sided prosthetic valve thrombosis.

Authors:  R P Balasundaram; G Karthikeyan; S S Kothari; K K Talwar; P Venugopal
Journal:  Heart       Date:  2005-06       Impact factor: 5.994

Review 5.  Thrombosis of prosthetic heart valves: diagnosis and therapeutic considerations.

Authors:  Raymond Roudaut; Karim Serri; Stephane Lafitte
Journal:  Heart       Date:  2007-01       Impact factor: 5.994

6.  Antithrombotic and thrombolytic therapy for valvular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Richard P Whitlock; Jack C Sun; Stephen E Fremes; Fraser D Rubens; Kevin H Teoh
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

7.  Tenecteplase in prosthetic mitral valve thrombosis.

Authors:  Masood Ayyub Ghori; Sherif Bakir; Samer Ellahham; Adnan Al Nassir; Abdulmajeed Al Zubaidi; Norbert Augustin; Moataz Ayman Abdelaziz; Nicolas Patrick Turrin; Wael Abdulrahman Al Mahmeed
Journal:  J Saudi Heart Assoc       Date:  2010-10-15

8.  Recurrent thrombotic obstruction of a mechanical prosthetic valve in tricuspid position. Value of cinefluoroscopy in diagnosis and follow-up of thrombolytic treatment.

Authors:  S Avci; S Yilmaz; O Kus; M F Ucar; D Aras
Journal:  Herz       Date:  2013-08-10       Impact factor: 1.443

9.  Horseshoe thrombus in a patient with mechanical prosthetic mitral valve: A case report and review of literature.

Authors:  Sanjay Mehra; Assad Movahed; Carlos Espinoza; Constantin B Marcu
Journal:  World J Clin Cases       Date:  2015-09-16       Impact factor: 1.337

10.  Effect of severe bioprosthetic valve tissue ingrowth and inflow calcification on valve-in-valve performance.

Authors:  Hoda Hatoum; Jennifer Dollery; Scott M Lilly; Juan A Crestanello; Lakshmi Prasad Dasi
Journal:  J Biomech       Date:  2018-05-04       Impact factor: 2.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.